Can Targeting the Incretin Pathway Dampen RAGE-Mediated Events in Diabetic Nephropathy?
Karly C Sourris, Henry Yao, George Jerums, Mark E Cooper, Elif I Ekinci, Melinda T Coughlan
Current Drug Targets | BENTHAM SCIENCE PUBL LTD | Published : 2016
This work was completed with support from the Diabetes Australia Research Trust (DART) and the Victorian Government's Operational Infrastructure Support Program. KS has been supported by the DART Viertel Postdoctoral Fellowship. MTC is supported by the Australian and New Zealand Society of Nephrology Career Development Fellowship. MEC is an NHMRC Research Fellow. EIE holds a part time NHMRC Early Career Health Professional Fellowship.